Local Coverage Determination (LCD)

Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography

L33950

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L33950
Original ICD-9 LCD ID
Not Applicable
LCD Title
Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography
Proposed LCD in Comment Period
N/A
Source Proposed LCD
N/A
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 12/07/2023
Revision Ending Date
N/A
Retirement Date
N/A
Notice Period Start Date
N/A
Notice Period End Date
N/A
AMA CPT / ADA CDT / AHA NUBC Copyright Statement

CPT codes, descriptions and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2023, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description

No changes

Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

Language quoted from Centers for Medicare and Medicaid Services (CMS), National Coverage Determinations (NCDs) and coverage provisions in interpretive manuals is italicized throughout the policy. NCDs and coverage provisions in interpretive manuals are not subject to the Local Coverage Determination (LCD) Review Process (42 CFR 405.860[b] and 42 CFR 426 [Subpart D]). In addition, an administrative law judge may not review an NCD. See Section 1869(f)(1)(A)(i) of the Social Security Act.

Unless otherwise specified, italicized text represents quotation from one or more of the following CMS sources:

Title XVIII of the Social Security Act (SSA):

Section 1862(a)(1)(A) excludes expenses incurred for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

Section 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.

Code of Federal Regulations:

21 CFR Section 900.11 specifies FDA certification requirements for suppliers of mammography services.

42 CFR Section 410.32, indicates that diagnostic tests may only be ordered by the treating physician (or other treating practitioner acting within the scope of his or her license and Medicare requirements) who furnishes a consultation or treats a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. Tests not ordered by the physician (or other qualified non-physician provider) who is treating the beneficiary are not reasonable and necessary (see Sec. 411.15(k)(1) of this chapter).

42 CFR Section 410.34 specifies the conditions for and limitation on coverage.

42 CFR, Section 486 specifies the conditions for coverage of portable x-ray services.

CMS Publications:

CMS Publication 100-02, Medicare Benefit Policy Manual, Chapter 15:

    80.4.3 Scope of Portable X-Ray Benefit

CMS Publication 100-02, Medicare Benefit Policy Manual, Chapter 15:

    80.4.4 Exclusions From Coverage as Portable X-Ray Services

CMS Publication 100-03, Medicare National Coverage Decisions Manual, Chapter 1:

    220.4 Mammograms

CMS Publication 100-03, Medicare National Coverage Decisions Manual, Chapter 1:

    220.5 Ultrasound Diagnostic Procedures

CMS Publication 100-04, Medicare Claims Processing Manual, Chapter 13:

    90 Services of Portable X-Ray Suppliers

CMS Publication 100-04, Medicare Claims Processing Manual, Chapter 18:

    20 Mammography Services (Screening and Diagnostic)

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

Abstract:

This LCD describes mammography, magnetic resonance imaging of the breast, ultrasonic evaluation of the breast, and ductography.

Screening mammography is a radiological procedure furnished to a woman without signs or symptoms of breast disease, for the purpose of early detection of breast cancer and includes a physician’s interpretation of the results. It is inherently bilateral. The minimum requirements of a screening mammogram are cranio-caudal (CC) and medio-lateral oblique (MLO) views.

A diagnostic mammography subsequent to a suspicious screening mammography may include extra views without repeating the cranio-caudal (CC) and medio-lateral oblique (MLO) views, when the two tests are performed within a reasonable proximity of time of each other.

Diagnostic mammography is the specific evaluation of a patient with signs or symptoms of a breast disorder, or with screening-detected abnormalities. The goal of this radiographic evaluation is to arrive at precise management decisions, such as sonography, magnetic resonance imaging (MRI), biopsy, etc. Diagnostic mammography is to be distinguished from screening mammography in that the latter is done on patients who are asymptomatic. The minimum requirements for a diagnostic mammogram are cranio-caudal (CC) and medio-lateral oblique (MLO) views. Additional views may be required, but are considered part of the complete diagnostic examination.

The components of a screening mammogram include the radiographic test (the mammogram itself), interpretation and report, and the communication of the results to the patient.

The components of a diagnostic mammogram include a brief history (reason for the exam), palpation of the breasts (when indicated), the radiographic test (the mammogram itself), interpretation and report, and the communication of the results to the patient.

Breast sonography is the ultrasonic evaluation of an abnormal breast lesion.

Breast MRI is the application of magnetic resonance principles to breast imaging.

Ductography (galactography) is a contrast-enhanced visualization of the breast ducts.

Indications:

Screening Mammography

Medicare covers annual screening mammography for all women age 40 and over, and one baseline screening mammography for women between the ages of 35-39. A screening mammography is not subject to the Part B deductible and coinsurancedoes not apply. Diagnostic mammograms are still subject to the deductible and coinsurance.

Medicare Part B covers screening mammography services if they are furnished by a supplier that meets the certification requirements in 21 CFR Section 900.11. The Mammography Quality Standards Act requires that all mammography centers that bill Medicare be certified by the Food and Drug Administration (FDA). Medicare will only reimburse FDA-certified mammography centers.


A physician's referral is not required for a screening mammography.

When a screening mammography detects a radiographic abnormality prompting the interpreting radiologist to order additional views on the same day, the interpreting radiologist may do so without an additional order from the treating physician and may bill for both the screening mammography and the diagnostic mammography.

Radiologists who order additional views (diagnostic mammogram) may do so without an additional order from the treating physician, but must refer to the treating physician or qualified non-physician practitioner for his/her NPI and report the condition of the patient back to the treating physician. If there is no treating/referring physician, the radiologist must report the exam results directly to the patient. The cost for additional views is included in the fee for the diagnostic mammography service.

A screening mammography is covered when provided by a hospital, physician (in office or clinic) or independent diagnostic testing facility (IDTF) but cannot be performed by a portable x-ray supplier.

Diagnostic Mammography

Diagnostic mammography is indicated when:

  • there are signs or symptoms suggestive of malignancy (e.g., mass, some types of spontaneous nipple discharge, skin changes, unilateral breast pain, or unilateral axillary lymph nodes);
  • there are radiographic abnormalities detected on screening mammography;
  • performed in a patient with metastatic disease of undetermined etiology, in whom the source is suspected to be breast;
  • performed on a patient with axillary lymphadenopathy of undetermined etiology; or
  • there is short interval follow-up (at six month intervals, for 2 years) necessary for unresolved clinical/radiographic concerns;
  • A personal history of breast malignancy exists.
  • Benign, biopsy-proven breast disease.
  • Medicare Part B covers diagnostic mammography services if they are furnished by a facility that meets the certification requirements of 21 CFR Section 900.11. The Mammography Quality Standards Act requires that all mammography centers that bill Medicare be certified by the Food and Drug Administration (FDA). Medicare will only reimburse FDA-certified mammography centers.

A treating provider's (physician or qualified non-physician practitioner) referral is required for a diagnostic mammography (except when performed at the discretion of the radiologist when prompted to do so by findings on the same day of the screening mammography). The referral should specify the diagnosis prompting the request for a diagnostic mammogram. When a screening mammogram is converted to a diagnostic mammogram, a note in the radiologist's report will fulfill this provision. This requirement is not applicable to hospital based radiologists for inpatient or outpatient diagnostic mammography.

Diagnostic mammography must be performed under the direct supervision of an interpreting physician qualified in mammography. The physician must be present and immediately available to furnish assistance and direction throughout the performance of the procedure. In the case of digital mammography, direct supervision may also be accomplished via telemammography. The radiologist need not be present as long as the interpreting physician is immediately available.

Diagnostic mammography may require that the performing radiologist review the history with the patient, review the prior mammograms, and perform an examination as part of the mammography. Also, the findings of the examination are typically discussed with the patient at the completion of the mammogram. Therefore, if telemammography is being used with digital diagnostic mammography, the radiologist need not be present for the mammography, however, he/she must be available to discuss the history with the patient, examine the patient and to discuss results of the findings of the examination with the patient within an acceptable period of time.

A diagnostic mammography is covered when provided by a hospital, physician (in office or clinic), independent diagnostic testing facility (IDTF) or portable x-ray supplier.

Breast Sonography

Breast sonography may be indicated for conditions such as:

  • Guidance for breast interventional procedures
  • Assessment of implant related problems
  • Radiation treatment planning
  • Initial evaluation of palpable masses in women under 30
  • In lactating and pregnant women
  • Assessment of palpable abnormalities on physical exam
  • Assessment to distinguish simple mastitis from abscess formation
  • Assessment of any mass to determine whether it is suitable for percutaneous intervention (core biopsy, for instance)
  • Assess stability of a sonographically visible mass that is mammographically invisible
  • Non-palpable masses, detected by mammography, to differentiate cysts from solid lesions
  • Palpable masses, if needle aspiration is not performed
  • Symptomatic, possible ruptured silicone breast prosthesis when an MRI is not planned
  • Calcifications to determine if an invasive component exists that would be amenable to core biopsy when supported by additional clinical indications.
  • Breast ultrasonography should not be routinely used along with diagnostic mammography. Ultrasonography may be indicated in addition to diagnostic mammography for the evaluation of some ambiguous mammographic or palpable masses or focal asymmetric densities that may represent or mask a mass.

Breast ultrasonography may be performed, in some cases, without having a diagnostic mammography first. However, an order from the treating physician for the ultrasonography is required. For example: a 22-year-old female presents with a painful breast lump. An ultrasound is performed and documents a large simple cyst, which subsequently is aspirated and resolved without the need for a prior diagnostic mammography.

A treating provider's (physician or qualified non-physician practitioner) order is required for breast ultrasound. This requirement is not applicable to hospital based radiologists for inpatient or outpatient breast ultrasound.

Breast sonography should be performed under the general supervision of a physician qualified in breast ultrasonography.

Breast MRI

Breast MRI studies are to be used very selectively. The modality should be restricted to:

  • cases where diagnosis is inconclusive, even after standard work-up;
  • evaluation of the post-operative patient when scar tissue cannot be differentiated from tumors;
  • patients with positive axillary nodes but no known primary;
  • patients with rupture of a breast implant; or
  • determination of the extent of disease in patients with known malignancy, prior to treatment (to assure confinement to one segment of the breast).
  • Breast MRI should be performed under the general supervision of a physician qualified in magnetic resonance imaging.

A treating provider's (physician or qualified non-physician practitioner) order is required for breast MRI.

Ductogram (Galactogram)

Ductography is useful as an aid in diagnosing the cause of an abnormal nipple discharge and is valuable in diagnosing intraductal papillomas.

Ductography should be performed under the personal supervision of a physician qualified in ductography.

A treating provider's (physician or qualified non-physician practitioner) referral is required for ductography.

Limitations:

The following limitations apply to screening mammography:

  • The service must be, at a minimum, a two-view exposure (cranio-caudal and a medial-lateral oblique view) of each breast.
  • Payment may not be made for screening mammography performed on a woman under age 35.
  • Payment may only be made for a screening mammography when performed after at least 11 months have passed following the month in which the last screening mammography service was rendered.
  • Mammography facilities that perform screening mammography services may not release screening mammography x-rays for interpretation to physicians who are not approved under the facilities certification number unless:
    • the patient has requested a transfer of the films from one facility to another for a second opinion, or
    • the patient has moved to another part of the country where the next screening mammography will be performed.
    • Only one type of screening mammography will be allowed in a calendar year. Either a screening mammography –film OR a screening mammography – digital will be paid.
    • A screening mammography is not payable for a male beneficiary.
    • The following limitations apply to diagnostic mammography
  • Only one type of diagnostic mammography will be allowed on the same claim. Either a diagnostic mammography –film OR diagnostic mammography – digital will be paid.
  • A diagnostic mammogram, a breast sonogram, or a breast MRI for a diagnosis of neoplasm of unspecified nature of bone, soft tissue and skin (D49.2) is acceptable only when related to the breast (i.e., metastasis).
  • An evaluation and management (E&M) service (e.g., CPT codes 99201-99275) should not be coded in addition to the mammogram on the same date or on a subsequent date, by a provider whose sole responsibility is the performance of the mammogram (e.g., a radiologist).
  • A physician such as an obstetrician, gynecologist, or breast surgeon may perform an E&M service in addition to the mammogram if there are separately identifiable services rendered other than the components of the mammogram.
  • The interpretation of a mammogram [Codes 77065, 77066, 77067with the 26 modifier] may not be billed by a provider reviewing the test as part of another service (e.g., E&M service) if the interpretation has already been billed by the mammographer.
  • Transportation costs are associated with mobile units for diagnostic mammography tests only. There is no separate transportation cost allowed for screening mammography, or other breast imaging procedures. To receive transportation payments, the approved portable x-ray supplier must also meet the certification requirements of Section 354 of the Public Health Service Act.
Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description
N/A

Revenue Codes

Code Description
N/A

CPT/HCPCS Codes

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information
N/A
Sources of Information

This bibliography presents those sources that were obtained during the development of this policy. CGS is not responsible for the continuing viability of Web site addresses listed below.

ACR Practice Guideline for the Performance of Screening and Diagnostic Mammography. 2008;525-534.

Adams JS, Song CF, Kantorovich V. Breast symptoms among women enrolled in a Health Maintenance Organization. Annals of Internal Medicine. 1999;130.

Berry DA. Benefits and risks of screening mammography for women in their forties: a statistical appraisal, Journal of the National Cancer Institute, 1998;90:19:1431-1439.

Ductogram (galactogram): imaging the breast ducts. Breast Health. http://www.imaginis.com/breasthealth/ductography.asp. Accessed March 26, 2009.

Expanded role of ultrasound in breast masses. Radiology. 1995;196.

High Definition Imaging: The role of ultrasound in the diagnosis of breast cancer (Summary of an international multicenter clinical study). ATL Ultrasound Reference Library.

Lehman C, Gatsonis C, Kuhl C, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356(13):1295-1303.

McGraw-Hill's, Access Medicine- Harrison's Internal Medicine, Chapter 86, Breast cancer (17th edition), screening.

McGraw-Hill's, Access Medicine- Harrison's Internal Medicine, Chapter 86, Breast Cancer (17th edition), Evaluation of breast masses in men and women.

National Guideline Clearinghouse. Recommended Breast Cancer Surveillance Guidelines. 1999.

Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75-89.

Screening vs. diagnostic mammography. CPT Assistant, Volume 6, Issue 7, July 1996.

Standards, American College of Radiology, Reston, VA, 1997.

U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002 ;137(5 Part 1):344-346.

What is Breast MRI? Department of Radiology, Magnetic Resonance Science Center at UC San Francisco.

Bibliography

N/A

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
12/07/2023 R21

R19

Revision Effective: 12/07/2023

Revision Explanation: Annual review, no changes were made.

11/29/2023: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Other (Annual Review)
12/01/2022 R20

R18

Revision Effective: 12/01/2022

Revision Explanation: Annual review, no changes were made.

11/23/2022: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Other (Annual Review)
11/25/2021 R19

R17

Revision Effective: 11/25/2021

Revision Explanation: Annual review, no changes were made.

11-19-2021: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Other (Annual Review)
11/28/2019 R18

R16

Revision Effective: n/a

Revision Explanation: annual review, no changes made

11/16/2020: At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Other (Annual Review)
11/28/2019 R17

R15

Revision Effective: n/a

Revision Explanation: annual review, no changes made

11/25/2019:At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Other (Annual REview, no changes made)
11/28/2019 R16

R14

Revision Effective: 11/28/2019

Revision Explanation: Removed other comments from coverage and limitations section and placed in the billing and coding article. Also moved the documentation information listed in the associated documents and placed in the billing and coding article.

11/20/2019:At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Provider Education/Guidance
09/12/2019 R15

R13

Revision Effective: 09/19/2019 Revision Explanation: Converted policy into new policy template that no longer includes coding section based on CR 10901. For Approval, no changes.

09/13/2019:At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Revisions Due To Code Removal
09/12/2019 R14

R12

Revision Effective: 09/19/2019 Revision Explanation: Converted policy into new policy template that no longer includes coding section based on CR 10901.

09/12/2019:At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Revisions Due To Code Removal
01/01/2019 R13

R11
Revision Effective: 03/28/2019
Revision Explanation: Removed all billing and coding details from policy into related Billing and Coding article. Coding information was removed based on CR10901.

03/25/2019:At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Other (Removed billing and coding details)
01/01/2019 R12

R11

Revision Effective date: 01/01/2019

Revision Explanation: During the annual HCPCS update the following codes were deleted: 77058, 77059, C8904, and C8907 and replaced with 77048-77049.

12/20/2018-At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Revisions Due To CPT/HCPCS Code Changes
01/01/2018 R11

R10

Revision Effective date: N/A

Revision Explanation: Annual review no changes

11/26/2018-At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Other (Annual review)
01/01/2018 R10

R9

Revision Effective: 01/01/2018

Revision Explanation: Added new codes 77065-77067 from annual HCPCS update. 77067 replaced G0202, 77065 replaced  G0206, and 77066 replaced G0204. Aldo removed ICD-10 codes N63.10 and N63.20 from group 2 and three diagnosis lists as these were added in error during the annual ICD-10 update in October 2017.

 

12/14/2017-At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

 

  • Revisions Due To CPT/HCPCS Code Changes
10/01/2017 R9

R8

Revision Effective: N/A

Revision Explanation: Annual review no changes made.

 

11/28/2017-At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Other (annual review)
10/01/2017 R8

R7

Revision Effective: 10/01/2017

Revision Explanation: During annual ICD-10 update N63.0 was deleted from group 2 and 3. This code was replaced with the codes listed below.

N63.10
N63.11
N63.12
N63.13
N63.14
N63.20
N63.21
N63.22
N63.23
N63.24
N63.31
N63.32
N63.41
N63.42

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Revisions Due To ICD-10-CM Code Changes
01/01/2017 R7 Revision#:R6
Revision Effective date: 01/01/2017
Revision Explanation: Updated policy to remove codes 77071, 77052, and 77055-77057 from the text of the policy as they are end dated effective 12/31/2016 and replaced with G0202, G0204, G0206 as they have new description for 2017.

Removed the following two sentences as computer aided detection is now included in the description for mammography codes.

Computer aided detection (CAD) code 77052 billed in conjunction with screening film or digital mammography codes does not require FDA certification.

Computer aided detection (CAD) code 77051 billed in conjunction with diagnostic film or digital mammography codes does not require FDA certification.
  • Revisions Due To CPT/HCPCS Code Changes
10/01/2016 R6 Revision#:R5
Revision Effective date: N/A
Revision Explanation: annual review no changes
  • Other (Annual Review)
10/01/2016 R5 Revision#: R4
Revision Effective: 10/01/2016
Revision Explanation: N61 was deleted and replaced with N61.0 and N61.1 for group 2 and 3 during annual ICD-10 update.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R4 Revision#: R3
Revision Effective: 10/01/2015
Revision Explanation: Annual review-Removed mention of supplemental article in indications section. CGS does not have an article for breast imaging.
  • Typographical Error
10/01/2015 R3 Revision#: R2
Revision Effective: N/A
Revision Explanation: Accepting revenue code description changes
  • Other (revenue code description changes)
10/01/2015 R2 Revision#: R2
Revision Effective: 10/01/2015
Revision Explanation: added 76641 and 76642 to paragraph over group 3 ICD-9 list to show which list is correct for these codes.
  • Provider Education/Guidance
10/01/2015 R1 Revision#: R1
Revision Effective: 10/01/2015
Revision Explanation: CPT code 76645 replaced with 76641 and 76642. Added new codes 77063 and G0279 for diagnostic mammography's.
  • Revisions Due To CPT/HCPCS Code Changes
N/A

Associated Documents

Attachments
N/A
Related National Coverage Documents
N/A
Public Versions
Updated On Effective Dates Status
11/29/2023 12/07/2023 - N/A Currently in Effect You are here
11/23/2022 12/01/2022 - 12/06/2023 Superseded View
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A

Read the LCD Disclaimer